Sort   by:  
 Page size 
GenomicsClinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Pancreatic adenocarcinoma has the worst mortality of any solid cancer. To evaluate the clinical implications of genomic alterations in this tumor type, we performed whole-exome analyses of 24 tumors, targeted genomic analyses of 77 tumors, and used non-invasive approaches to examine tumor-specific ...
EGAS00001001257 | EGA
Genomicsena-DATASET-JHU-29-06-2015-20:17:30:536-212 - samples
Clinical Implications of Genomic Alterations in the Tumour and Circulation of Pancreatic Cancer Patients
EGAD00001001421 | EGA
GenomicsPancreatic Adenocarcinoma Data Access Committee
Data Access Committee EGAC00001000358
EGAC00001000358 | EGA
GenomicsThe Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer world-wide with 1.2 million patients diagnosed yearly. In late stage CRC, the most commonly used targeted therapies are monoclonal antibodies cetuximab and panitumumab, which inactivate EGFR. Recent studies have identified alterations in KRAS...
EGAS00001001305 | EGA
Genomicsena-DATASET-JHUSM-28-09-2015-22:11:53:244-560 - samples
Description not provided
EGAD00001001628 | EGA
Genomicsena-DATASET-JHUSM-16-11-2015-19:53:19:325-4 - samples
Description not provided
EGAD00001001674 | EGA
GenomicsDAC for the study of response to EGFR Blockade in Colorectal Cancer
Data Access Committee EGAC00001000360
EGAC00001000360 | EGA
Sort   by:  
 Page size